mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.8 |